You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股爆「抽水潮」眾安(06060.HK)曾挫一成 宏橋(01378.HK)續破頂 創新藥股受壓榮昌(09995.HK)曾瀉25%
因港元匯價觸及7.85弱方兌換保證,香港金管局自2023年以來首次在市場買入94.2億港元。遇企業「抽水潮」,港股四連升後今早(26日)回落,恆指低開129點,報24,345後,初段曾跌233點,低見24,240,隨後跌幅收窄,最新報24,383,跌90點或近0.4%,成交1253.18億元。科指低開後倒升,最新報5,371,升0.25%。 大市波幅有限,焦點股份備受關注。信達生物(01801.HK)曾跌5.5%低見77.9元。現報78.9元,跌4.25%,成交20.31億元。其宣布折讓4.9%配股,淨籌42.7億元。 眾安在線(06060.HK)曾跌10.3%低見17.88元後跌幅收窄。現報19.32元,跌3.11%,成交21.69億元。其宣布折讓8.5%配股淨籌近39億元。 順豐控股(06936.HK)曾跌7%最低見42.95元。現報44.5元,跌3.68%,成交4.36億元。其擬折讓8.8%配股另溢價4.9%發可換股債,共淨籌逾58億元。 國泰君安國際(01788.HK)獲香港證監會批出加密貨幣交易資格,該股繼上日急升近兩倍後,今早(26日)高開14.9%後持續抽上,盤中曾高見7.02元一度炒上89.73%,其後升幅收窄,最新報4.4元,升18.92%,成交164.98億元超上日全日(上日成交163.85億元)。 中國宏橋(01378.HK)早前發盈喜,料上半年純利按年升約35%,今早低開0.2%後倒升,高見17.78元再創歷史高。現報17.6元,升2.56%,成交3.68億元。 三大新消費「明星股」表現分化,泡泡瑪特(09992.HK)現報253.2元,升2.34%,成交15.32億元。老鋪黃金(06181.HK)現報852.5元,跌1.27%,成交3.07億元。蜜雪(02097.HK)現報509元,跌3.23%,成交1.21億元。 創新藥概念A股受壓,連帶H股受拖累走低。榮昌生物(09995.HK)向Vor Bio授出泰它西普大中華外獨家開發權,惟榮昌A股(688331.SH)初段曾20cm跌停,近中午收市最新跌逾14%,報57.35元人民幣。榮昌生物H股今早低開14.77%,初段曾挫逾25%低見50.05元。現報56.65元,跌15.51%,成交19.24億元。 另德琪醫藥-B(06996.HK)跌11.25%,報2.92元,成交1,634.89萬元。康方生物(09926.HK)、開拓藥業-B(09939.HK)、科濟藥業-B(02171.HK)亦跌3.4%至4.5%。百濟神州(06160.HK)、科倫博泰-B(06990.HK)、康希諾生物(06185.HK)及金斯瑞(01548.HK)跌1.5%至2.9%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account